Albumin human - PharmaKB

Albumin human

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

2886 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Breast neoplasms	D001943	EFO_0003869	C50	74	198	75	14	36	363
Carcinoma	D002277	—	C80.0	73	183	50	2	14	291
Pancreatic neoplasms	D010190	EFO_0003860	C25	87	126	18	4	18	212
Non-small-cell lung carcinoma	D002289	—	—	45	118	56	3	6	206
Neoplasms	D009369	—	C80	115	62	8	5	20	183
Lung neoplasms	D008175	—	C34.90	37	101	43	3	9	176
Squamous cell carcinoma	D002294	—	—	28	93	20	1	5	132
Triple negative breast neoplasms	D064726	—	—	29	64	22	3	3	111
Liver cirrhosis	D008103	EFO_0001422	K74.0	3	22	16	12	57	98
Fibrosis	D005355	—	—	5	21	14	10	51	90

Show 190 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Adenocarcinoma	D000230	—	—	52	107	40	—	7	173
Ovarian neoplasms	D010051	EFO_0003893	C56	44	63	26	—	3	125
Ovarian epithelial carcinoma	D000077216	—	—	29	44	21	—	4	91
Recurrence	D012008	—	—	21	50	17	—	4	83
Fallopian tube neoplasms	D005185	—	—	22	31	20	—	1	67
Uterine cervical neoplasms	D002583	—	—	9	22	12	—	2	40
Peritoneal neoplasms	D010534	—	—	17	10	11	—	2	37
Covid-19	D000086382	—	U07.1	6	13	5	—	15	37
Pancreatic ductal carcinoma	D021441	—	—	17	24	3	—	2	35
Serous cystadenocarcinoma	D018284	—	—	9	17	13	—	—	34

Show 166 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Renal cell carcinoma	D002292	EFO_0000376	—	12	7	—	—	3	19
Sclerosis	D012598	—	—	3	9	—	—	6	16
Lymphoma	D008223	—	C85.9	9	2	—	—	3	14
Left ventricular dysfunction	D018487	—	—	4	7	—	—	3	10
Multiple sclerosis	D009103	EFO_0003885	G35	3	4	—	—	3	9
Cystic fibrosis	D003550	EFO_0000390	E84	4	1	—	—	4	9
Ventricular dysfunction	D018754	—	—	4	7	—	—	2	9
Leukemia	D007938	—	C95	3	4	—	—	2	8
Multiple myeloma	D009101	—	C90.0	2	2	—	—	4	8
Kidney neoplasms	D007680	EFO_0003865	C64	3	3	—	—	2	8

Show 208 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Fatty liver	D005234	EFO_0003934	—	1	—	—	—	9	10
Inflammatory bowel diseases	D015212	EFO_0003767	—	1	—	—	—	9	10
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	1	—	—	—	6	7
Malaria	D008288	EFO_0001068	B54	5	—	—	—	—	5
Prediabetic state	D011236	EFO_1001121	R73.03	2	—	—	—	3	5
Pulmonary fibrosis	D011658	—	J84.10	1	—	—	—	4	5
Hodgkin disease	D006689	—	C81	3	—	—	—	1	4
Multiple organ failure	D009102	EFO_1001373	—	1	—	—	—	3	4
Bariatric surgery	D050110	—	—	1	—	—	—	3	4
Cysts	D003560	—	—	1	—	—	—	3	4

Show 109 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Intestinal diseases	D007410	—	K63.9	—	—	—	—	8	8
Bone fractures	D050723	EFO_0003931	T14.8	—	—	—	—	7	7
Arthritis	D001168	EFO_0005856	M05-M14	—	—	—	—	6	6
Delirium	D003693	—	R41.0	—	—	—	—	6	6
Gestational diabetes	D016640	—	O24.4	—	—	—	—	6	6
Emergence delirium	D000071257	—	—	—	—	—	—	5	5
Hip fractures	D006620	EFO_0003964	S72.00	—	—	—	—	5	5
Acidosis	D000138	EFO_1000014	E87.2	—	—	—	—	5	5
Retinal perforations	D012167	EFO_1001028	—	—	—	—	—	5	5
Nervous system diseases	D009422	—	G00-G99	—	—	—	—	4	4